Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jie Wu, Maolan Li, Yijian Zhang, Yan Cai & Gaiping Zhao. (2018) Molecular mechanism of activated T cells in breast cancer. OncoTargets and Therapy 11, pages 5015-5024.
Read now
Read now
Qishu Zhang, Lijun Qiao, Xiao Wang, Changkuan Ding & Jason J. Chen. (2018) UHRF1 epigenetically down-regulates UbcH8 to inhibit apoptosis in cervical cancer cells. Cell Cycle 17:3, pages 300-308.
Read now
Read now
Wouter Hendrickx, Ines Simeone, Samreen Anjum, Younes Mokrab, François Bertucci, Pascal Finetti, Giuseppe Curigliano, Barbara Seliger, Luigi Cerulo, Sara Tomei, Lucia Gemma Delogu, Cristina Maccalli, Ena Wang, Lance D. Miller, Francesco M. Marincola, Michele Ceccarelli & Davide Bedognetti. (2017) Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis. OncoImmunology 6:2.
Read now
Read now
Shuo Wang & Antonis E. Koromilas. (2016) STAT1-mediated translational control in tumor suppression and antitumor therapies. Molecular & Cellular Oncology 3:3.
Read now
Read now
Articles from other publishers (34)
Rawiah A. Alsiary, Talat Abdullah Albukhari & Waheed A. Filimban. 2023. Molecular Targets and Cancer Therapeutics (Part 1). Molecular Targets and Cancer Therapeutics (Part 1)
273
319
.
Nurul Athirah Nasarudin, Mohd Saberi Mohamad, Zalmiyah Zakaria, Richard O. Sinnott, Fatma Al Jasmi & Noura Al Dhaheri. (2023) Identification of informative genes and sub-pathways using Improved Differential Expression Analysis for Pathways (iDEAP) for cancer classification. F1000Research 12, pages 1433.
Crossref
Crossref
Grace L. Wong, Sara G. Manore, Daniel L. Doheny & Hui-Wen Lo. (2022) STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges. Seminars in Cancer Biology 86, pages 84-106.
Crossref
Crossref
Jing Zhang, Mingyue Fan, Chanjuan Jin, Zhaoying Wang, Yutong Yao, Yueru Shi, Xin Hu & Youzhong Wan. (2022) NFIC1 suppresses migration and invasion of breast cancer cells through interferon-mediated Jak-STAT pathway. Archives of Biochemistry and Biophysics 727, pages 109346.
Crossref
Crossref
Qingbo Li, Fengxian Tan, Yuanyuan Wang, Xiaohui Liu, Xianbin Kong, Jingyan Meng, Long Yang & Shan Cen. (2022) The gamble between oncolytic virus therapy and IFN. Frontiers in Immunology 13.
Crossref
Crossref
Dingchang Li, Yanan Jiao, Wenxing Gao, Shidong Hu, Dingling Li, Wen Zhao, Peng Chen, Lujia Jin, Yingjie Zhao, Zhaofu Ma, Xiansheng Wu, Yang Yan, Wen Sun, Xiaohui Du & Guanglong Dong. (2022) Comprehensive analysis of the prognostic and immunotherapeutic implications of STAT family members in human colorectal cancer. Frontiers in Genetics 13.
Crossref
Crossref
Audrey Nédélec, Emilie M. Guérit, Guillaume Dachy, Sandrine Lenglez, Lok San Wong, Florence A. Arts & Jean‐Baptiste Demoulin. (2022)
Penttinen syndrome‐associated
PDGFRB
Val665Ala variant causes aberrant constitutive
STAT1
signalling
. Journal of Cellular and Molecular Medicine 26:14, pages 3902-3912.
Crossref
Crossref
Manel Benhassine, Gaëtan Le-Bel & Sylvain L. Guérin. (2022) Contribution of the STAT Family of Transcription Factors to the Expression of the Serotonin 2B (HTR2B) Receptor in Human Uveal Melanoma. International Journal of Molecular Sciences 23:3, pages 1564.
Crossref
Crossref
Bocheng Wu, Quaovi H. Sodji & Adegboyega K. Oyelere. (2022) Inflammation, Fibrosis and Cancer: Mechanisms, Therapeutic Options and Challenges. Cancers 14:3, pages 552.
Crossref
Crossref
Nicole M. NaranjoIsraa SalemMaisha A. HarrisLucia R. Languino. (2021) IFIT3 (interferon induced protein with tetratricopeptide repeats 3) modulates STAT1 expression in small extracellular vesicles. Biochemical Journal 478:21, pages 3905-3921.
Crossref
Crossref
Kei Nakamura, Atsushi Shiozaki, Toshiyuki Kosuga, Hiroki Shimizu, Michihiro Kudou, Takuma Ohashi, Tomohiro Arita, Hirotaka Konishi, Shuhei Komatsu, Takeshi Kubota, Hitoshi Fujiwara, Kazuma Okamoto, Mitsuo Kishimoto, Eiichi Konishi & Eigo Otsuji. (2021) The expression of the alpha1 subunit of Na+/K+-ATPase is related to tumor development and clinical outcomes in gastric cancer. Gastric Cancer 24:6, pages 1278-1292.
Crossref
Crossref
Kang LI, Dawei YUAN, Wei CHEN, Rulan MA & Yinsheng XIAN. (2021) (S)-(-)-N-[2-(3-Hydroxy-2-oxo-2,3-dihydro-1H-indol-3-yl)-ethyl]-acetamide inhibits colon cancer growth via the STAT1 pathway. Food Science and Technology.
Crossref
Crossref
Yuyin Fu, Yujia Peng, Shengyan Zhao, Jun Mou, Lishi Zeng, Xiaohua Jiang, Chengli Yang, Cheng Huang, Yuyan Li, Yin Lu, Mengdan Wu, Yanfang Yang, Ting Kong, Qinhuai Lai, Yangping Wu, Yuqin Yao, Yuxi Wang, Lantu Gou & Jinliang Yang. (2021) Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal Carcinoma. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Mayank Jain, Mukul Kumar Singh, Hari Shyam, Archana Mishra, Shailendra Kumar, Ambrish Kumar & Jitendra Kushwaha. (2022) Role of JAK/STAT in the Neuroinflammation and its Association with Neurological Disorders. Annals of Neurosciences 28:3-4, pages 191-200.
Crossref
Crossref
Sayantan Banik, Sudeshna Rakshit & Koustav Sarkar. (2021) The Role of STAT1 in T Helper Cell Differentiation during Breast Cancer Progression. Journal of Breast Cancer 24:3, pages 253.
Crossref
Crossref
Manish Charan, Ajeet K. Verma, Shahid Hussain, Swati Misri, Sanjay Mishra, Sarmila Majumder, Bhuvaneswari Ramaswamy, Dinesh Ahirwar & Ramesh K. Ganju. (2020) Molecular and Cellular Factors Associated with Racial Disparity in Breast Cancer. International Journal of Molecular Sciences 21:16, pages 5936.
Crossref
Crossref
Li Zhao, Xiangquan Li, Jing Su, Fenfei Wang Gong, Junjie Lu & Yuzhen Wei. (2020)
STAT1
determines aggressiveness of glioblastoma both in vivo and in vitro through wnt/β‐catenin signalling pathway
. Cell Biochemistry and Function 38:5, pages 630-641.
Crossref
Crossref
Dieuwertje E. Kok, Ciara H. O’Flanagan, Michael F. Coleman, Zahra Ashkavand, Stephen D. Hursting & Sergey A. Krupenko. (2020) Effects of folic acid withdrawal on transcriptomic profiles in murine triple-negative breast cancer cell lines. Biochimie 173, pages 114-122.
Crossref
Crossref
Ling-Wei Hii, Felicia Fei-Lei Chung, Chun Wai Mai, Zong Yang Yee, Hong Hao Chan, Vijay Joseph Raja, Noah Elias Dephoure, Nigel J. Pyne, Susan Pyne & Chee-Onn Leong. (2020) Sphingosine Kinase 1 Regulates the Survival of Breast Cancer Stem Cells and Non-stem Breast Cancer Cells by Suppression of STAT1. Cells 9:4, pages 886.
Crossref
Crossref
Yannick Verhoeven, Sam Tilborghs, Julie Jacobs, Jorrit De Waele, Delphine Quatannens, Christophe Deben, Hans Prenen, Patrick Pauwels, Xuan Bich Trinh, An Wouters, Evelien L.J. Smits, Filip Lardon & Peter A. van Dam. (2020) The potential and controversy of targeting STAT family members in cancer. Seminars in Cancer Biology 60, pages 41-56.
Crossref
Crossref
Anna Orlova, Christina Wagner, Elvin D. de Araujo, Dávid Bajusz, Heidi A. Neubauer, Marco Herling, Patrick T. Gunning, György M. Keserű & Richard Moriggl. (2019) Direct Targeting Options for STAT3 and STAT5 in Cancer. Cancers 11:12, pages 1930.
Crossref
Crossref
Elena Butturini, Alessandra Carcereri de Prati, Diana Boriero & Sofia Mariotto. (2019) Natural Sesquiterpene Lactones Enhance Chemosensitivity of Tumor Cells through Redox Regulation of STAT3 Signaling. Oxidative Medicine and Cellular Longevity 2019, pages 1-16.
Crossref
Crossref
Vanessa Daza-Cajigal, Adriana S. Albuquerque, Joanna Pearson, Jennifer Hinley, Andrew S. Mason, Jens Stahlschmidt, Adrian J. Thrasher, Vibhash Mishra, Jennifer Southgate & Siobhan O. Burns. (2019) Loss of Janus Associated Kinase 1 Alters Urothelial Cell Function and Facilitates the Development of Bladder Cancer. Frontiers in Immunology 10.
Crossref
Crossref
Merit L. Goodman, Gloria M. Trinca, Katherine R. Walter, Evangelia K. Papachristou, Clive S. D’Santos, Tianbao Li, Qi Liu, Zhao Lai, Prabhakar Chalise, Rashna Madan, Fang Fan, Mary A. Markiewicz, Victor X. Jin, Jason S. Carroll & Christy R. Hagan. (2019) Progesterone Receptor Attenuates STAT1-Mediated IFN Signaling in Breast Cancer. The Journal of Immunology 202:10, pages 3076-3086.
Crossref
Crossref
Sonia Leon-Cabrera, Armando Vázquez-Sandoval, Emmanuel Molina-Guzman, Yael Delgado-Ramirez, Norma Delgado-Buenrostro, Blanca Callejas, Yolanda Chirino, Carlos Pérez-Plasencia, Miriam Rodríguez-Sosa, Jonadab Olguín, Citlaltepetl Salinas, Abhay Satoskar & Luis Terrazas. (2018) Deficiency in STAT1 Signaling Predisposes Gut Inflammation and Prompts Colorectal Cancer Development. Cancers 10:9, pages 341.
Crossref
Crossref
Yuan Chen, Lei Fang, Jiali Zhang, Gefei Li, Mengni Ma, Changxi Li, Jianxin Lyu & Qing Meng. (2017) Blockage of Glyoxalase I Inhibits Colorectal Tumorigenesis and Tumor Growth via Upregulation of STAT1, p53, and Bax and Downregulation of c-Myc and Bcl-2. International Journal of Molecular Sciences 18:3, pages 570.
Crossref
Crossref
Valeriya Malysheva, Marco Antonio Mendoza-Parra, Mohamed-Ashick M. Saleem & Hinrich Gronemeyer. (2016) Reconstruction of gene regulatory networks reveals chromatin remodelers and key transcription factors in tumorigenesis. Genome Medicine 8:1.
Crossref
Crossref
Fadia J.A. Gujam, Donald C. McMillan & Joanne Edwards. (2016) The relationship between total and phosphorylated STAT1 and STAT3 tumour cell expression, components of tumour microenvironment and survival in patients with invasive ductal breast cancer. Oncotarget 7:47, pages 77607-77621.
Crossref
Crossref
Katrina K Au, Cécile Le Page, Runhan Ren, Liliane Meunier, Isabelle Clément, Kathrin Tyrishkin, Nichole Peterson, Jennifer Kendall‐Dupont, Timothy Childs, Julie‐Ann Francis, Charles H Graham, Andrew W Craig, Jeremy A Squire, Anne‐Marie Mes‐Masson & Madhuri Koti. (2016)
STAT1‐associated intratumoural T
H
1 immunity predicts chemotherapy resistance in high‐grade serous ovarian cancer
. The Journal of Pathology: Clinical Research 2:4, pages 259-270.
Crossref
Crossref
Chengsheng WuOmmoleila MolaviHaifeng ZhangNidhi GuptaAbdulraheem AlshareefKathleen M. BoneKeshav GopalFang WuJamie T. Lewis, Donna N. Douglas, Norman M. Kneteman & Raymond Lai. (2015) STAT1 is phosphorylated and downregulated by the oncogenic tyrosine kinase NPM-ALK in ALK-positive anaplastic large-cell lymphoma. Blood 126:3, pages 336-345.
Crossref
Crossref
Shuo WangChristos Patsis & Antonis E. Koromilas. (2015) Stat1 stimulates cap-independent mRNA translation to inhibit cell proliferation and promote survival in response to antitumor drugs. Proceedings of the National Academy of Sciences 112:17.
Crossref
Crossref
A. Dittrich, H. Gautrey, D. Browell & A. Tyson-Capper. (2014) The HER2 Signaling Network in Breast Cancer—Like a Spider in its Web. Journal of Mammary Gland Biology and Neoplasia 19:3-4, pages 253-270.
Crossref
Crossref
Richard Carpenter & Hui-Wen Lo. (2014) STAT3 Target Genes Relevant to Human Cancers. Cancers 6:2, pages 897-925.
Crossref
Crossref
Nicole R. Leitner, Caroline Lassnig, Rita Rom, Susanne Heider, Zsuzsanna Bago-Horvath, Robert Eferl, Simone Müller, Thomas Kolbe, Lukas Kenner, Thomas Rülicke, Birgit Strobl & Mathias Müller. (2014) Inducible, Dose-Adjustable and Time-Restricted Reconstitution of Stat1 Deficiency In Vivo. PLoS ONE 9:1, pages e86608.
Crossref
Crossref